Ítem
Acceso Abierto
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women
dc.creator | Insinga, Ralph P. | spa |
dc.creator | Perez, Gonzalo | spa |
dc.creator | Wheeler, Cosette M. | spa |
dc.creator | Koutsky, Laura A. | spa |
dc.creator | Garland, Suzanne M. | spa |
dc.creator | Leodolter, Sepp | spa |
dc.creator | Joura, Elmar A. | spa |
dc.creator | Ferris, Daron G. | spa |
dc.creator | Steben, Marc | spa |
dc.creator | Brown, Darron R. | spa |
dc.creator | Elbasha, Elamin H. | spa |
dc.creator | Paavonen, Jorma | spa |
dc.creator | Haupt, Richard M. | spa |
dc.date.accessioned | 2020-05-26T00:03:48Z | |
dc.date.available | 2020-05-26T00:03:48Z | |
dc.date.created | 2010 | spa |
dc.description.abstract | Background: We describe the incidence and duration of cervical human papillomavirus (HPV) infection episodes along with the risk of infection reappearance following a period of nondetection. Methods:Women (1,788) ages 16 to 23 years underwent cytologic testing and PCR-based testing of cervical swab samples for HPV DNA (HPV-16/18/31/33/35/45/52/58/59) at ?6-month intervals for up to 4 years in the context of a phase 3 clinical trial (placebo arm). HPV type - specific incidence rates were estimated per 100 person-years. Duration of type-specific cervical infection episodes and risk of reappearance following a period of nondetection were estimated using Kaplan-Meier methods. Results: HPV-16 exhibited the highest (5.9), and HPV-35 and HPV-33 exhibited the lowest (1.0) incidence rates per 100 person-years. Mean cervical infection durations ranged from 13 months for HPV-59 to 20 months for HPV-16 and 58 (with ongoing infections censored at the time of treatment, if done). The risk of cervical infection reappearance within ?3 years following a period of nondetection ranged from 0% to 16% across HPV types, with a mean of 8%. Limited evidence was found for a role of false-positive HPV tests, missed infections that were above the threshold for detection, or new acquisition of infection in accounting for patterns of infection reappearance. Conclusions: Incidence of high-risk cervical infection was observed to vary considerably more across HPV types than infection duration. A nontrivial proportion of women exhibited infection reappearance following a period of nondetection, with a potential explanation for many such events observed within this analysis being a return to detectable levels of a previously acquired infection. Impact: The risk of HPV infection reappearance following a period of nondetection has not been previously reported for individual HPV types, and this study finds that a nontrivial proportion of infected women exhibit reappearances. Future studies could ascertain subject-level factors that potentially modify the risk of infection reappearance. ©2010 AACR. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1158/1055-9965.EPI-09-1235 | |
dc.identifier.issn | 10559965 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/23631 | |
dc.language.iso | eng | spa |
dc.publisher | American Association for Cancer Research Inc. | spa |
dc.relation.citationEndPage | 1594 | |
dc.relation.citationIssue | No. 6 | |
dc.relation.citationStartPage | 1585 | |
dc.relation.citationTitle | Cancer Epidemiology Biomarkers and Prevention | |
dc.relation.citationVolume | Vol. 19 | |
dc.relation.ispartof | Cancer Epidemiology Biomarkers and Prevention, ISSN:10559965, Vol.19, No.6 (2010); pp. 1585-1594 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953297415&doi=10.1158%2f1055-9965.EPI-09-1235&partnerID=40&md5=c4ff1e71c6f202e566a47b5eee621114 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Adolescent | spa |
dc.subject.keyword | phase iii as topic | eng |
dc.subject.keyword | Article | spa |
dc.subject.keyword | Clinical feature | spa |
dc.subject.keyword | Clinical trial | spa |
dc.subject.keyword | Controlled study | spa |
dc.subject.keyword | Cytology | spa |
dc.subject.keyword | Disease classification | spa |
dc.subject.keyword | Disease duration | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Human tissue | spa |
dc.subject.keyword | Incidence | spa |
dc.subject.keyword | Major clinical study | spa |
dc.subject.keyword | Papillomavirus infection | spa |
dc.subject.keyword | Polymerase chain reaction | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Uterine cervix | spa |
dc.subject.keyword | Double blind procedure | spa |
dc.subject.keyword | Genetics | spa |
dc.subject.keyword | Isolation and purification | spa |
dc.subject.keyword | Papilloma virus | spa |
dc.subject.keyword | Papillomavirus infections | spa |
dc.subject.keyword | Phase 3 clinical trial (topic) | spa |
dc.subject.keyword | Prevalence | spa |
dc.subject.keyword | Randomized controlled trial (topic) | spa |
dc.subject.keyword | Uterine cervical diseases | spa |
dc.subject.keyword | Virology | spa |
dc.subject.keyword | Young adult | spa |
dc.subject.keyword | Virus dna | spa |
dc.subject.keyword | Adolescent | spa |
dc.subject.keyword | Clinical trials | eng |
dc.subject.keyword | Dna | eng |
dc.subject.keyword | Double-blind method | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Incidence | spa |
dc.subject.keyword | Papillomaviridae | spa |
dc.subject.keyword | Papillomavirus infections | spa |
dc.subject.keyword | Polymerase chain reaction | spa |
dc.subject.keyword | Prevalence | spa |
dc.subject.keyword | Randomized controlled trials as topic | spa |
dc.subject.keyword | Uterine cervical diseases | spa |
dc.subject.keyword | Young adult | spa |
dc.title | Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- 1585-full.pdf
- Tamaño:
- 256.65 KB
- Formato:
- Adobe Portable Document Format
- Descripción: